Where innovation moves us
| Date - Category | Illustration | Title | Excerpt |
|---|---|---|---|
|
|
26 September 2025 Plan-Les-Ouates & Zurich (CH) – Antwerp (BE) Spineart (www.spineart.com), a global medtech innovator in advanced spine surgery solutions, today announces a CHF 25 million capital increase backed...
|
|
|
|
Spineart announces the full-market launch of its SCARLET® AC-Ti secured anterior cervical cage in the United States. Following 510(k) clearance in May 2024, SCARLET® AC-Ti has been extensively evaluated by...
|
|
|
|
Spineart today announces that it has completed a planned interim analysis for its 2-level BAGUERA® C IDE study, which showed that BAGUERA® C, its innovative cervical disc prosthesis, met the...
|
|
|
|
Spineart and eCential Robotics proudly announce the 510(k) clearance from the U.S. Food and Drug Administration (FDA) of the Spineart PERLA® TL application (PERLA® App) for use with the new...
|
|
|
|
Spineart today announces that it has completed a planned interim analysis for its 1-level BAGUERA®C IDE study, which showed that BAGUERA® C, its innovative cervical disc prosthesis, met...
|